FR2198M - Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques. - Google Patents

Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques.

Info

Publication number
FR2198M
FR2198M FR915206A FR915206A FR2198M FR 2198 M FR2198 M FR 2198M FR 915206 A FR915206 A FR 915206A FR 915206 A FR915206 A FR 915206A FR 2198 M FR2198 M FR 2198M
Authority
FR
France
Prior art keywords
estrogenic
new drug
hypocholesterolemic properties
hypocholesterolemic
properties
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR915206A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR906814A external-priority patent/FR1341550A/fr
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Priority to FR915206A priority Critical patent/FR2198M/fr
Application granted granted Critical
Publication of FR2198M publication Critical patent/FR2198M/fr
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
FR915206A 1961-08-14 1962-11-13 Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques. Active FR2198M (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR915206A FR2198M (fr) 1961-08-14 1962-11-13 Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques.

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US131094A US3142683A (en) 1961-08-14 1961-08-14 1-pyridyl-1, 2-diaryl-3-trifluoro-propan-2-ols and a process for their preparation
FR906814A FR1341550A (fr) 1962-08-13 1962-08-13 Composés halogénés et procédés de préparation de tels composés
FR915206A FR2198M (fr) 1961-08-14 1962-11-13 Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques.

Publications (1)

Publication Number Publication Date
FR2198M true FR2198M (fr) 1963-12-09

Family

ID=22447852

Family Applications (1)

Application Number Title Priority Date Filing Date
FR915206A Active FR2198M (fr) 1961-08-14 1962-11-13 Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques.

Country Status (4)

Country Link
US (1) US3142683A (fr)
DE (1) DE1195314B (fr)
FR (1) FR2198M (fr)
GB (1) GB962294A (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422153A (en) * 1966-03-09 1969-01-14 Lilly Co Eli Novel aryl-substituted propenes and derivatives
FR2440353A1 (fr) * 1978-11-03 1980-05-30 Science Union & Cie Nouveaux arylethanols, leurs procedes d'obtention et leur emploi comme medicament

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2727899A (en) * 1953-06-30 1955-12-20 Olin Mathieson Certain 1-cycloalkyl, 1-aryl, omega-c-pyridyl, or c-quinolyl, 1-alkanols, salts and process
US2749351A (en) * 1953-09-04 1956-06-05 Raschig Gmbh Dr F Process for the production of pyridine aldehydes and pyridoines
US2961443A (en) * 1957-04-10 1960-11-22 Ethyl Corp Organic compounds of boron
US2863802A (en) * 1957-04-11 1958-12-09 Diamond Alkali Co Treating plants with the systemically active fungicide, lower alkyl, 2(3, 3, 3-trihalo-2-hydroxypropyl)-pyridine
US2909525A (en) * 1957-08-08 1959-10-20 Warner Lambert Pharmaceutical Anti-fungal compounds

Also Published As

Publication number Publication date
US3142683A (en) 1964-07-28
GB962294A (en) 1964-07-01
DE1195314B (de) 1965-06-24

Similar Documents

Publication Publication Date Title
FR1916M (fr) Médicament a base de 16.α-méthyl-6-α-fluoro-1.4-prégnadiene-11.β.21-diol-3.20-dione.
FR2198M (fr) Nouveau médicament a propriétés oestrogenes et hypocholestérolemiques.
FR3168M (fr) Nouveaux médicaments androgéniques et anaboliques.
FR3139M (fr) 1-halogénophényl-2-amino-alcanones-(1) secondaires et tertiaires a propriétés thérapeutiques.
FR296M (fr) Médicament hypoazotémique et hypocholestérolémiant.
FR2183M (fr) Nouveau médicament a propriétés hormonales et hypocholestérolémiques.
FR2400M (fr) Nouveau médicament antalgique neuro-trophique et anti-anémique.
FR1084M (fr) Médicament a propriétés anti-inflammatoires.
FR1361M (fr) Nouveau médicament hypocholestérolémique.
FR2511M (fr) Nouveau médicament a propriétés antiinfectieuses.
FR1849M (fr) Nouveau médicament neurosédatif, hypnogene et relaxant musculaire.
FR2945M (fr) Nouveau médicament a propriétés antimycotiques.
FR1072M (fr) Nouveau médicament a action hypocholestérolémiante.
FR1429M (fr) Nouveau médicament antirhumatismal et anti-inflammatoire.
FR1353M (fr) Nouveau médicament sédatif et hypnogene.
FR2634M (fr) Médicament nouveau a propriétés hypnotiques et sédatives.
FR1864M (fr) Médicament nouveau a base de mercapto-acyl-amido-5-nitrothiazoles.
FR1486M (fr) Nouveau médicament anti-coagulant.
FR387M (fr) Nouveau médicament parasympatholytique et antispasmodique.
FR3265M (fr) Diluant pharmaceutique.
FR1066M (fr) Nouveau médicament a usage local kératoplastique et décongestionnant.
FR2567M (fr) Nouveau médicament antiathéromateux et antilipémique.
FR2351M (fr) Médicament a action tonique et régulatrice.
BE615935A (fr) Nouveau médicament à action hypocholestérolémiante
FR1054M (fr) Médicament a action tuberculostatique.